Skip to main content
Premium Trial:

Request an Annual Quote

Roche Gets CE-IVD Mark for MRSA Test

NEW YORK (GenomeWeb News) – Roche has received the CE-IVD Mark in Europe for its LightCycler test for methicillin-resistant Staphylococcus aureus allowing it to be sold for clinical use in the EU, the firm said today.

The assay provides direct detection of nasal colonization with MRSA and runs on Roche's LightCycler 2.0 instrument using PCR.

Roche will compete in the European clinical market with Cepheid and Becton Dickinson, which both sell MRSA and SA/MRSA molecular screening tests. Cepheid's Xpert MRSA/SA Nasal molecular diagnostic test received the CE-IVD Mark earlier this week.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.